Compositions for regenerating defective or absent myocardium
US-9199001-B2 · Dec 1, 2015 · US
Poultry performance
US9394515B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9394515-B2 |
| Application number | US-201414184002-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 19, 2014 |
| Priority date | Feb 22, 2013 |
| Publication date | Jul 19, 2016 |
| Grant date | Jul 19, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Methods for increasing breast muscle weight in poultry are disclosed herein. These methods can include delivery of compositions via in ovo administration. The methods disclosed herein also encompass the delivery of proteins. The methods disclosed herein are effective for increasing breast muscle weight in poultry, both in the embryo, and at slaughter age.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method of increasing muscle mass in a chicken, comprising the steps of: a) administering a composition comprising between about 10-40 ng of Fibroblast Growth Factor-2; and a pharmaceutically acceptable carrier in ovo to an embryonated chicken egg between embryonal day 0 and embryonal day 4; and b) incubating said embryonated chicken egg until hatch; wherein said Fibroblast Growth Factor-2 is selected from SEQ ID NO.1 or SEQ ID NO. 3. 2. The method of claim 1 wherein said administration occurs on about embryonal day 0. 3. The method of claim 1 wherein said administration occurs on about embryonal day 1 (ED1). 4. The method of claim 1 wherein said administration occurs on about embryonal day 2 (ED2). 5. The method of claim 1 wherein said administration occurs on about embryonal day 3 (ED3). 6. The method of claim 1 wherein said administration occurs on about embryonal day 4 (ED4).
Assignees
Inventors
Classifications
Solutions {(composition of solutions A61K47/00)} · CPC title
- A61K38/1825Primary
Fibroblast growth factor [FGF] · CPC title
Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2 {(insulin-like growth factor binding protein A61K38/1754)} · CPC title
Polymeric derivatives, e.g. peptides or proteins · CPC title
Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2 · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9394515B2 cover?
- Methods for increasing breast muscle weight in poultry are disclosed herein. These methods can include delivery of compositions via in ovo administration. The methods disclosed herein also encompass the delivery of proteins. The methods disclosed herein are effective for increasing breast muscle weight in poultry, both in the embryo, and at slaughter age.
- Who is the assignee on this patent?
- Zoetis Services Llc
- What technology area does this patent fall under?
- Primary CPC classification A61K38/1825. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).